| Visible light photocatalytic activity of Ag/WO3 nanoparticles and its antibacterial activity under ambient light and in the dark M Matalkeh, GK Nasrallah, FM Shurrab, ES Al-Absi, W Mohammed, ... Results in Engineering 13, 100313, 2022 | 47 | 2022 |
| Diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic SARS-COV-2 … S Younes, H Al-Jighefee, F Shurrab, DW Al-Sadeq, N Younes, ... Microorganisms 9 (2), 245, 2021 | 36 | 2021 |
| Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies HM Yassine, H Al-Jighefee, DW Al-Sadeq, SR Dargham, SN Younes, ... International journal of infectious diseases 102, 181-187, 2021 | 33 | 2021 |
| Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals DW Al-Sadeq, FM Shurrab, A Ismail, FH Amanullah, S Thomas, N Aldewik, ... Journal of Travel Medicine 28 (8), taab190, 2021 | 28 | 2021 |
| Severe acute respiratory syndrome coronavirus‐2 natural animal reservoirs and experimental models: systematic review S Younes, N Younes, F Shurrab, GK Nasrallah Reviews in medical virology 31 (4), e2196, 2021 | 26 | 2021 |
| Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in … FM Shurrab, N Younes, DW Al-Sadeq, N Liu, H Qotba, LJ Abu-Raddad, ... International Journal of Infectious Diseases 118, 132-137, 2022 | 20 | 2022 |
| Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population GK Nasrallah, SR Dargham, F Shurrab, DW Al-Sadeq, H Al-Jighefee, ... Scientific reports 11 (1), 11837, 2021 | 18 | 2021 |
| Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays. A Ismail, FM Shurrab, HT Al-Jighefee, DW Al-Sadeq, H Qotba, IA Al-Shaar, ... IMR, 2021 | 12 | 2021 |
| Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection H Abou-Saleh, BY Abo-Halawa, S Younes, N Younes, DW Al-Sadeq, ... Journal of Travel Medicine 29 (8), taac130, 2022 | 10 | 2022 |
| Low risk of serological cross-reactivity between the dengue virus and SARS-CoV-2-IgG antibodies using advanced detection assays FM Shurrab, DW Al-Sadeq, FH Amanullah, ES Al-Absi, H Qotba, ... Intervirology 65 (4), 224-229, 2022 | 8 | 2022 |
| Effect of multiple freeze–thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies FM Shurrab, DW Al-Sadeq, F Amanullah, SN Younes, H Al-Jighefee, ... Journal of Medical Microbiology 70 (8), 001402, 2021 | 8 | 2021 |
| Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection A Ismail, FM Shurrab, HT Al-Jighefee, DW Al-Sadeq, H Qotba, IA Al-Shaar, ... A comparative study between three different assays, 2021 | 8 | 2021 |
| Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting GK Nasrallah, SR Dargham, F Shurrab, DW Al-Sadeq, H Al-Jighefee, ... medRxiv, 2020.12. 14.20248163, 2020 | 7 | 2020 |
| Validation of a novel fluorescent lateral flow assay for rapid qualitative and quantitative assessment of total anti-SARS-CoV-2 S-RBD binding antibody units (BAU) from plasma … N Younes, DW Al-Sadeq, FM Shurrab, HT Zedan, H Abou-Saleh, ... Vaccines 10 (8), 1318, 2022 | 6 | 2022 |
| Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above MA Syed, AS Al Nuaimi, HA A/Qotba, GK Nasrallah, AA Althani, ... BMC infectious diseases 21, 1-11, 2021 | 4 | 2021 |
| Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar GK Nasrallah, SR Dargham, DW Al-Sadeq, FH Amanullah, FM Shurrab, ... Virology journal 20 (1), 188, 2023 | 3 | 2023 |
| Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study FM Shurrab, DW Al-Sadeq, H Abou-Saleh, N Al-Dewik, AE Elsharafi, ... Vaccines 10 (2), 191, 2022 | 3 | 2022 |
| ZnO-Doped gC3N4 Nanocapsules for Enhancing the Performance of Electroless NiP Coating─Mechanical, Corrosion Protection, and Antibacterial Properties F Nabhan, EM Fayyad, MH Sliem, FM Shurrab, K Eid, G Nasrallah, ... ACS omega 8 (25), 22361-22381, 2023 | 1 | 2023 |
| Visible Light Photocatalytic Activity of Ag/WO3 Nanoparticles and its Antibacterial Activity Under Ambient Light and in The Dark M Maha, GK Nasrallah, FM Shurrab, ES Al-Absi, W Mohammed, ... Elsevier, 2022 | 1 | 2022 |
| Seroprevalence of SARS-CoV2 in Qatar: a longitudinal epidemiological study F Shurrab, H Al-Jighefee, S Younes, D Al-Sadeq, A Althani, H Yassine, ... Qatar University Press, 2020 | 1 | 2020 |
